Arkana Therapeutics is an early-stage biotechnology company developing novel therapies for obesity and metabolic disease. Inspired by animals with extreme metabolic adaptations, Arkana is building complementary programs that address both sides of energy balance: reducing calories consumed through appetite suppression and increasing calories burned through energy expenditure. The immediate focus of this role is Arkana's lead appetite suppression program.